1. The past time-series ILI occurrences over the 5 weeks exhibited a generally declining trend, with values of ['1395', '1315', '1243', '1309', '1140']. Although there was a slight increase from 1243 (Week 37, 2021) to 1309 (Week 38, 2021), the overall trajectory was downward, culminating at 1140 in Week 39, 2021, the lowest in the observed period. This indicates a sustained decline in ILI activity during this timeframe.  

2. Despite the declining trend in past ILI occurrences, the future occurrences reaching 1228 (Week 44, 2021) suggest a slight recovery or stabilization after a low point at 1140 (Week 39, 2021). The fluctuation between Weeks 37 and 38, along with the minimal reduction from 1140 to 1228, reflects a moderate correlation between past ILI decreases and the modest rebound after 5 weeks.  

3. Several observations from the CDC reports are relevant to the modest recovery in future ILI occurrences:  
   - Nationwide outpatient visits for ILI remained consistently low across all weeks, ranging from 0.9% (Week 35, 2021) to 1.9% (Week 38, 2021), below the baseline of 2.6%. However, this stability in baseline ILI activity may have contributed to the rebound to 1228.  
   - The percentage of deaths attributed to pneumonia, influenza, or COVID-19 (PIC) remained significantly above epidemic thresholds across all weeks, e.g., 21.0% in Week 36, 2021, and 18.7% in Week 39, 2021, driven primarily by COVID-19. This heightened mortality from respiratory illnesses may indirectly reflect general increases in respiratory illness activity, including ILI.  
   - CDC reports consistently noted increased ILI patterns driven by other respiratory viruses, rather than influenza. For instance, Weeks 36 and 38 documented that other circulating viruses likely explained recent upticks in ILI trends, suggesting these viruses may have contributed to the 1228 future occurrences.  

4. In summary, the future ILI occurrences of 1228 (Week 44, 2021) can be attributed to a stabilization or rebound following the lowest observed past ILI value (1140 in Week 39, 2021). Despite a declining trend in past occurrences, consistent reporting of baseline ILI activity, persistent higher PIC-driven mortality, and the influence of other respiratory pathogens, likely fostered this modest increase.